Company news

Lantern Pharma Inc. news in 2020

Lantern Pharma Inc.'s news releases, calls and decks from 2020, newest first.

View company

Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at Johns Hopkins to Further Develop LP-184 as Therapy for Glioblastoma

December 16, 2020

Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Barrier Permeability for Drug Candidate LP-184 in Glioblastoma and Potentially Other CNS Cancers

December 14, 2020

Lantern Pharma Announces Upcoming Conference Presentations

November 23, 2020

Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational Progress

October 28, 2020

Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown University for LP-184, a Next-Generation, Targeted DNA-Damaging Agent

October 4, 2020

Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer Center Focused on Advancing the Development of LP-184 in Pancreatic Cancer

September 21, 2020

Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate Progress

July 29, 2020

Lantern Pharma Announces Two Presentations at American Association for Cancer Research (AACR) 2020 Virtual Annual Meeting

June 16, 2020

Lantern Pharma Announces Closing of Initial Public Offering

June 14, 2020

Decks in 2020